A Two-Stage, p16^INK4A- and p53-Dependent Keratinocyte Senescence Mechanism That Limits Replicative Potential Independent of Telomere Status

REFERENCES

• Alani, R. M., J. Hasskarl, M. Grace, M. C. Hernandez, M. A. Israel, and K. Munger. 1999. Immortalization of primary human keratinocytes by the helix-loop-helix protein, Id-1. Proc. Natl. Acad. Sci. USA 96: 9637–9641.
   PubMedGoogle Scholar
• Alani, R. M., A. Z. Young, and C. B. Shifflett. 2001. Id1 regulation of cellular senescence through transcriptional repression of p16/Ink4a. Proc. Natl. Acad. Sci. USA 98: 7812–7816.
   PubMedGoogle Scholar
• Alcorta, D. A., Y. Xiong, D. Phelps, G. Hannon, D. Beach, and J. C. Barrett. 1996. Involvement of the cyclin-dependent kinase inhibitor p16 (INK4a) in replicative senescence of normal human fibroblasts. Proc. Natl. Acad. Sci. USA 93: 13742–13747.
   PubMed Web of Science ®Google Scholar
• Allen-Hoffmann, B. L., and J. G. Rheinwald. 1984. Polycyclic aromatic hydrocarbon mutagenesis of human epidermal keratinocytes in culture. Proc. Natl. Acad. Sci. USA 81: 7802–7806.
   PubMed Web of Science ®Google Scholar
• Allsopp, R. C., H. Vaziri, C. Patterson, S. Goldstein, E. V. Younglai, A. B. Futcher, C. W. Greider, and C. B. Harley. 1992. Telomere length predicts replicative capacity of human fibroblasts. Proc. Natl. Acad. Sci. USA 89: 10114–10118.
   PubMed Web of Science ®Google Scholar
• Atamna, H., A. Paler-Martinez, and B. N. Ames. 2000. N-t-Butyl hydroxylamine, a hydrolysis product of α-phenyl-N-t-butyl nitrone, is more potent in delaying senescence in human lung fibroblasts. J. Biol. Chem. 275: 6741–6748.
   PubMed Web of Science ®Google Scholar
• Bodnar, A. G., M. Ouellette, M. Frolkis, S. E. Holt, C. P. Chiu, G. B. Morin, C. B. Harley, J. W. Shay, S. Lichtsteiner, and W. E. Wright. 1998. Extension of life-span by introduction of telomerase into normal human cells. Science 279: 349–352.
   PubMed Web of Science ®Google Scholar
• Bond, J. A., F. S. Wyllie, and D. Wynford-Thomas. 1994. Escape from senescence in human diploid fibroblasts induced directly by mutant p53. Oncogene 9: 1885–1889.
   PubMedGoogle Scholar
• Boyce, S. T., and R. G. Ham. 1983. Calcium-regulated differentiation of normal human epidermal keratinocytes in chemically defined clonal culture and serum-free serial culture. J. Investig. Dermatol. 81: 33s–40s.
   PubMed Web of Science ®Google Scholar
• Boyle, J. O., J. Hakim, W. Koch, P. van der Riet, R. H. Hruban, R. A. Roa, R. Correo, Y. J. Eby, J. M. Ruppert, and D. Sidransky. 1993. The incidence of p53 mutations increases with progression of head and neck cancer. Cancer Res. 53: 4477–4480.
   PubMed Web of Science ®Google Scholar
• Brenner, A. J., M. R. Stampfer, and C. M. Aldaz. 1998. Increased p16 expression with first senescence arrest in human mammary epithelial cells and extended growth capacity with p16 inactivation. Oncogene 17: 199–205.
   PubMed Web of Science ®Google Scholar
• Brown, J. P., W. Wei, and J. M. Sedivy. 1997. Bypass of senescence after disruption of p21CIP1/WAF1 gene in normal diploid human fibroblasts. Science 277: 831–834.
   PubMed Web of Science ®Google Scholar
• Califano, J., P. van der Riet, W. Westra, H. Nawroz, G. Clayman, S. Piantadosi, R. Corio, D. Lee, B. Greenberg, W. Koch, and D. Sidransky. 1996. Genetic progression model for head and neck cancer: implications for field cancerization. Cancer Res. 56: 2488–2492.
   PubMed Web of Science ®Google Scholar
• Connell, N. D., and J. G. Rheinwald. 1983. Regulation of the cytoskeleton in mesothelial cells: reversible loss of keratin and increase in vimentin during rapid growth in culture. Cell 34: 245–253.
   PubMed Web of Science ®Google Scholar
• Counter, C. M., F. M. Botelho, P. Wang, C. B. Harley, and S. Bacchetti. 1994. Stabilization of short telomeres and telomerase activity accompany immortalization of Epstein-Barr virus-transformed human B lymphocytes. J. Virol. 68: 3410–3414.
   PubMed Web of Science ®Google Scholar
• Dellambra, E., O. Golisano, S. Bondanza, E. Siviero, P. Lacal, M. Molinari, S. D'Atri, and M. De Luca. 2000. Downregulation of 14-3-3sigma prevents clonal evolution and leads to immortalization of primary human keratinocytes. J. Cell Biol. 149: 1117–1130.
   PubMed Web of Science ®Google Scholar
• Dickson, M. A., W. C. Hahn, Y. Ino, V. Ronfard, J. Y. Wu, R. A. Weinberg, D. N. Louis, F. P. Li, and J. G. Rheinwald. 2000. Human keratinocytes that express hTERT and also bypass a p16INK4a-enforced mechanism that limits life span become immortal yet retain normal growth and differentiation characteristics. Mol. Cell. Biol. 20: 1436–1447.
   PubMed Web of Science ®Google Scholar
• Dimri, G. P., K. Itahana, M. Acosta, and J. Campisi. 2000. Regulation of a senescence checkpoint response by the E2F1 transcription factor and p14ARF tumor suppressor. Mol. Cell. Biol. 20: 273–285.
   PubMed Web of Science ®Google Scholar
• Donehower, L. A., M. Harvey, B. L. Slagle, M. J. McArthur, C. A. Montgomery, Jr., J. S. Butel, and A. Bradley. 1992. Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours. Nature 356: 215–221.
   PubMed Web of Science ®Google Scholar
• Farwell, D. G., K. A. Shera, J. I. Koop, G. A. Bonnet, C. P. Matthews, G. W. Reuther, M. D. Coltrera, J. K. McDougall, and A. J. Klingelhutz. 2000. Genetic and epigenetic changes in human epithelial cells immortalized by telomerase. Am. J. Pathol. 156: 1537–1547.
   PubMedGoogle Scholar
• Foster, S. A., D. J. Wong, M. T. Barrett, and D. A. Galloway. 1998. Inactivation of p16 in human mammary epithelial cells by CpG island methylation. Mol. Cell. Biol. 18: 1793–1801.
   PubMed Web of Science ®Google Scholar
• Gombart, A. F., R. Yang, M. J. Campbell, J. D. Berman, and H. P. Koeffler. 1997. Inhibition of growth of human leukemia cell lines by retrovirally expressed wild-type p16INK4A. Leukemia 11: 1673–1680.
   PubMed Web of Science ®Google Scholar
• Gottlieb, E., R. Haffner, T. von Ruden, E. F. Wagner, and M. Oren. 1994. Down-regulation of wild-type p53 activity interferes with apoptosis of IL-3-dependent hematopoietic cells following IL-3 withdrawal. EMBO J. 13: 1368–1374.
   PubMed Web of Science ®Google Scholar
• Hahn, W. C., C. M. Counter, A. S. Lundberg, R. L. Beijersbergen, M. W. Brooks, and R. A. Weinberg. 1999. Creation of human tumour cells with defined genetic elements. Nature 400: 464–468.
   PubMed Web of Science ®Google Scholar
• Howley, P. M., and D. R. Lowy. 2001. Papillomaviruses and their replication, p. 2198–2229. In D. M. Knipe and P. M. Howley (ed.), Virology. Lippincott, Philadelphia, Pa.
   Google Scholar
• Hudson, D. L., K. L. Weiland, T. P. Dooley, M. Simon, and F. M. Watt. 1992. Characterisation of eight monoclonal antibodies to involucrin. Hybridoma 11: 367–379.
   PubMed Web of Science ®Google Scholar
• Jacobs, J. J., K. Kieboom, S. Marino, R. A. DePinho, and M. van Lohuizen. 1999. The oncogene and Polycomb-group gene bmi-1 regulates cell proliferation and senescence through the ink4a locus. Nature 397: 164–168.
   PubMed Web of Science ®Google Scholar
• Jarrard, D. F., S. Sarkar, Y. Shi, T. R. Yeager, G. Magrane, H. Kinoshita, N. Nassif, L. Meisner, M. A. Newton, F. M. Waldman, and C. A. Reznikoff. 1999. p16/pRb pathway alterations are required for bypassing senescence in human prostate epithelial cells. Cancer Res. 59: 2957–2964.
   PubMed Web of Science ®Google Scholar
• Johnson, E. W., S. F. Meunier, C. J. Roy, and N. L. Parenteau. 1992. Serial cultivation of normal human keratinocytes: a defined system for studying the regulation of growth and differentiation. In Vitro Cell Dev. Biol. 28A: 429–435.
   PubMed Web of Science ®Google Scholar
• Kamijo, T., E. van de Kamp, M. J. Chong, F. Zindy, J. A. Diehl, C. J. Sherr, and P. J. McKinnon. 1999. Loss of the ARF tumor suppressor reverses premature replicative arrest but not radiation hypersensitivity arising from disabled atm function. Cancer Res. 59: 2464–2469.
   PubMedGoogle Scholar
• Kiyono, T., S. A. Foster, J. I. Koop, J. K. McDougall, D. A. Galloway, and A. J. Klingelhutz. 1998. Both Rb/p16INK4a inactivation and telomerase activity are required to immortalize human epithelial cells. Nature 396: 84–88.
   PubMed Web of Science ®Google Scholar
• Krimpenfort, P., K. C. Quon, W. J. Mooi, A. Loonstra, and A. Berns. 2001. Loss of p16Ink4a confers susceptibility to metastatic melanoma in mice. Nature 413: 83–86.
   PubMed Web of Science ®Google Scholar
• Lindberg, K., M. E. Brown, H. V. Chaves, K. R. Kenyon, and J. G. Rheinwald. 1993. In vitro propagation of human ocular surface epithelial cells for transplantation. Investig. Ophthalmol. Vis. Sci. 34: 2672–2679.
   PubMed Web of Science ®Google Scholar
• Lindberg, K., and J. G. Rheinwald. 1990. Three distinct keratinocyte subtypes identified in human oral epithelium by their patterns of keratin expression in culture and in xenografts. Differentiation 45: 230–241.
   PubMedGoogle Scholar
• Loughran, O., A. Malliri, D. Owens, P. H. Gallimore, M. A. Stanley, B. Ozanne, M. C. Frame, and E. K. Parkinson. 1996. Association of CDKN2A/p16INK4A with human head and neck keratinocyte replicative senescence: relationship of dysfunction to immortality and neoplasia. Oncogene 13: 561–568.
   PubMed Web of Science ®Google Scholar
• Lukas, C., S. K. Jensen, J. Bartkova, J. Lukas, and J. Bartek. 1999. Immunohistochemical analysis of the D-type cyclin-dependent kinases Cdk4 and Cdk6, with a series of monoclonal antibodies. Hybridoma 18: 225–234.
   PubMedGoogle Scholar
• Manabe, M., H. W. Lim, M. Winzer, and C. A. Loomis. 1999. Architectural organization of filiform papillae in normal and black hairy tongue epithelium: dissection of differentiation pathways in a complex human epithelium according to their patterns of keratin expression. Arch. Dermatol. 135: 177–181.
   PubMedGoogle Scholar
• Mao, L., J. S. Lee, Y. H. Fan, J. Y. Ro, J. G. Batsakis, S. Lippman, W. Hittelman, and W. K. Hong. 1996. Frequent microsatellite alterations at chromosomes 9p21 and 3p14 in oral premalignant lesions and their value in cancer risk assessment. Nat. Med. 2: 682–685.
   PubMed Web of Science ®Google Scholar
• Miller, A. D., and G. J. Rosman. 1989. Improved retroviral vectors for gene transfer and expression. BioTechniques 7: 980–982, 984-986, 989-990.
   PubMed Web of Science ®Google Scholar
• Morgenstern, J. P., and H. Land. 1990. Advanced mammalian gene transfer: high titre retroviral vectors with multiple drug selection markers and a complementary helper-free packaging cell line. Nucleic Acids Res. 18: 3587–3596.
   PubMed Web of Science ®Google Scholar
• Murphy, J. E., and J. G. Rheinwald. 1997. Intraperitoneal injection of genetically modified, human mesothelial cells for systemic gene therapy. Hum. Gene Ther. 8: 1867–1879.
   PubMedGoogle Scholar
• Nickoloff, B. J., V. Chaturvedi, P. Bacon, J. Z. Qin, M. F. Denning, and M. O. Diaz. 2000. Id-1 delays senescence but does not immortalize keratinocytes. J. Biol. Chem. 275: 27501–27504.
   PubMed Web of Science ®Google Scholar
• Nielsen, G. P., A. O. Stemmer-Rachamimov, J. Shaw, J. E. Roy, J. Koh, and D. N. Louis. 1999. Immunohistochemical survey of p16INK4A expression in normal human adult and infant tissues. Lab. Investig. 79: 1137–1143.
   PubMed Web of Science ®Google Scholar
• Ohtani, N., Z. Zebedee, T. J. Huot, J. A. Stinson, M. Sugimoto, Y. Ohashi, A. D. Sharrocks, G. Peters, and E. Hara. 2001. Opposing effects of Ets and Id proteins on p16INK4a expression during cellular senescence. Nature 409: 1067–1070.
   PubMed Web of Science ®Google Scholar
• Oren, M. 1999. Regulation of the p53 tumor suppressor protein. J. Biol. Chem. 274: 36031–36034.
   PubMed Web of Science ®Google Scholar
• Papadimitrakopoulou, V., J. Izzo, S. M. Lippman, J. S. Lee, Y. H. Fan, G. Clayman, J. Y. Ro, W. N. Hittelman, R. Lotan, W. K. Hong, and L. Mao. 1997. Frequent inactivation of p16INK4a in oral premalignant lesions. Oncogene. 14: 1799–1803.
   PubMed Web of Science ®Google Scholar
• Parenteau, N. L., C. M. Nolte, P. Bilbo, M. Rosenberg, L. M. Wilkins, E. W. Johnson, S. Watson, V. S. Mason, and E. Bell. 1991. Epidermis generated in vitro: practical considerations and applications. J. Cell Biochem. 45: 245–251.
   PubMed Web of Science ®Google Scholar
• Parry, D., S. Bates, D. J. Mann, and G. Peters. 1995. Lack of cyclin D-Cdk complexes in Rb-negative cells correlates with high levels of p16INK4/MTS1 tumour suppressor gene product. EMBO J. 14: 503–511.
   PubMed Web of Science ®Google Scholar
• Pellegrini, G., E. Dellambra, O. Golisano, E. Martinelli, I. Fantozzi, S. Bondanza, D. Ponzin, F. McKeon, and M. De Luca. 2001. p63 identifies keratinocyte stem cells. Proc. Natl. Acad. Sci. USA 98: 3156–3161.
   PubMed Web of Science ®Google Scholar
• Pirisi, L., S. Yasumoto, M. Feller, J. Doniger, and J. A. DiPaolo. 1987. Transformation of human fibroblasts and keratinocytes with human papillomavirus type 16 DNA. J. Virol. 61: 1061–1066.
   PubMed Web of Science ®Google Scholar
• Puthenveettil, J. A., M. S. Burger, and C. A. Reznikoff. 1999. Replicative senescence in human uroepithelial cells. Adv. Exp. Med. Biol. 462: 83–91.
   PubMed Web of Science ®Google Scholar
• Ramirez, R. D., C. P. Morales, B. S. Herbert, J. M. Rohde, C. Passons, J. W. Shay, and W. E. Wright. 2001. Putative telomere-independent mechanisms of replicative aging reflect inadequate growth conditions. Genes Dev. 15: 398–403.
   PubMed Web of Science ®Google Scholar
• Reed, A. L., J. Califano, P. Cairns, W. H. Westra, R. M. Jones, W. Koch, S. Ahrendt, Y. Eby, D. Sewell, H. Nawroz, J. Bartek, and D. Sidransky. 1996. High frequency of p16 (CDKN2/MTS-1/INK4A) inactivation in head and neck squamous cell carcinoma. Cancer Res. 56: 3630–3633.
   PubMed Web of Science ®Google Scholar
• Rheinwald, J. G., and M. A. Beckett. 1980. Defective terminal differentiation in culture as a consistent and selectable character of malignant human keratinocytes. Cell 22: 629–632.
   PubMed Web of Science ®Google Scholar
• Rheinwald, J. G., and H. Green. 1975. Serial cultivation of strains of human epidermal keratinocytes: the formation of keratinizing colonies from single cells. Cell 6: 331–343.
   PubMed Web of Science ®Google Scholar
• Romanov, S. R., B. K. Kozakiewicz, C. R. Holst, M. R. Stampfer, L. M. Haupt, and T. D. Tlsty. 2001. Normal human mammary epithelial cells spontaneously escape senescence and acquire genomic changes. Nature 409: 633–637.
   PubMed Web of Science ®Google Scholar
• Sandhu, C., D. M. Peehl, and J. Slingerland. 2000. p16INK4A mediates cyclin dependent kinase 4 and 6 inhibition in senescent prostatic epithelial cells. Cancer Res. 60: 2616–2622.
   PubMedGoogle Scholar
• Schon, M., and J. G. Rheinwald. 1996. A limited role for retinoic acid and retinoic acid receptors RAR alpha and RAR beta in regulating keratin 19 expression and keratinization in oral and epidermal keratinocytes. J. Investig. Dermatol. 107: 428–438.
   PubMedGoogle Scholar
• Serrano, M., G. J. Hannon, and D. Beach. 1993. A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4. Nature 366: 704–707.
   PubMed Web of Science ®Google Scholar
• Serrano, M., H. Lee, L. Chin, C. Cordon-Cardo, D. Beach, and R. A. DePinho. 1996. Role of the INK4a locus in tumor suppression and cell mortality. Cell 85: 27–37.
   PubMed Web of Science ®Google Scholar
• Shapiro, G. I., C. D. Edwards, M. E. Ewen, and B. J. Rollins. 1998. p16INK4A participates in a G1 arrest checkpoint in response to DNA damage. Mol. Cell. Biol. 18: 378–387.
   PubMedGoogle Scholar
• Sharpless, N. E., N. Bardeesy, K. H. Lee, D. Carrasco, D. H. Castrillon, A. J. Aguirre, E. A. Wu, J. W. Horner, and R. A. DePinho. 2001. Loss of p16Ink4a with retention of p19Arf predisposes mice to tumorigenesis. Nature 413: 86–91.
   PubMed Web of Science ®Google Scholar
• Shaulian, E., A. Zauberman, D. Ginsberg, and M. Oren. 1992. Identification of a minimal transforming domain of p53: negative dominance through abrogation of sequence-specific DNA binding. Mol. Cell. Biol. 12: 5581–5592.
   PubMed Web of Science ®Google Scholar
• Sherr, C. J., and R. A. DePinho. 2000. Cellular senescence: mitotic clock or culture shock? Cell 102: 407–410.
   PubMed Web of Science ®Google Scholar
• Sherr, C. J., and J. D. Weber. 2000. The ARF/p53 pathway. Curr. Opin. Genet. Dev. 10: 94–99.
   PubMed Web of Science ®Google Scholar
• Stein, G. H., L. F. Drullinger, A. Soulard, and V. Dulic. 1999. Differential roles for cyclin-dependent kinase inhibitors p21 and p16 in the mechanisms of senescence and differentiation in human fibroblasts. Mol. Cell. Biol. 19: 2109–2117.
   PubMed Web of Science ®Google Scholar
• Tao, W., and A. J. Levine. 1999. p19(ARF) stabilizes p53 by blocking nucleo-cytoplasmic shuttling of Mdm2. Proc. Natl. Acad. Sci. USA 96: 6937–6941.
   PubMed Web of Science ®Google Scholar
• Tsao, H., X. Zhang, K. Kwitkiwski, D. M. Finkelstein, A. J. Sober, and F. G. Haluska. 2000. Low prevalence of germline CDKN2A and CDK4 mutations in patients with early-onset melanoma. Arch. Dermatol. 136: 1118–1122.
   PubMedGoogle Scholar
• Tubo, R. A., and J. G. Rheinwald. 1987. Normal human mesothelial cells and fibroblasts transfected with the EJras oncogene become EGF-independent, but are not malignantly transformed. Oncogene Res. 1: 407–421.
   PubMedGoogle Scholar
• Walker, G. J., B. G. Gabrielli, M. Castellano, and N. K. Hayward. 1999. Functional reassessment of P16 variants with a transfection-based assay. Int. J. Cancer 82: 305–312.
   PubMedGoogle Scholar
• Weber, J. D., L. J. Taylor, M. F. Roussel, C. J. Sherr, and D. Bar-Sagi. 1999. Nucleolar Arf sequesters Mdm2 and activates p53. Nat. Cell Biol. 1: 20–26.
   PubMed Web of Science ®Google Scholar
• Wei, W., R. M. Hemmer, and J. M. Sedivy. 2001. Role of p14ARF in replicative and induced senescence of human fibroblasts. Mol. Cell. Biol. 21: 6748–6757.
   PubMedGoogle Scholar
• Weinstein, G. D., and E. J. Van Scott. 1965. Autoradiographic analysis of turnover times of normal and psoriatic epidermis. J. Investig. Dermatol. 45: 257–262.
   PubMed Web of Science ®Google Scholar
• Wolfel, T., M. Hauer, J. Schneider, M. Serrano, C. Wolfel, E. Klehmann-Hieb, E. De Plaen, T. Hankeln, K. H. Meyer zum Buschenfelde, and D. Beach. 1995. A p16INK4a-insensitive CDK4 mutant targeted by cytolytic T lymphocytes in a human melanoma. Science 269: 1281–1284.
   PubMed Web of Science ®Google Scholar
• Wright, W. E., and J. W. Shay. 2001. Cellular senescence as a tumor-protection mechanism: the essential role of counting. Curr. Opin. Genet. Dev. 11: 98–103.
   PubMed Web of Science ®Google Scholar
• Wu, Y. J., L. M. Parker, N. E. Binder, M. A. Beckett, J. H. Sinard, C. T. Griffiths, and J. G. Rheinwald. 1982. The mesothelial keratins: a new family of cytoskeletal proteins identified in cultured mesothelial cells and nonkeratinizing epithelia. Cell 31: 693–703.
   PubMed Web of Science ®Google Scholar
• Yang, A., M. Kaghad, Y. Wang, E. Gillett, M. D. Fleming, V. Dotsch, N. C. Andrews, D. Caput, and F. McKeon. 1998. p63, a p53 homolog at 3q27-29, encodes multiple products with transactivating, death-inducing, and dominant-negative activities. Mol. Cell 2: 305–316.
   PubMed Web of Science ®Google Scholar
• Yang, J., E. Chang, A. M. Cherry, C. D. Bangs, Y. Oei, A. Bodnar, A. Bronstein, C. P. Chiu, and G. S. Herron. 1999. Human endothelial cell life extension by telomerase expression. J. Biol. Chem. 274: 26141–26148.
   PubMed Web of Science ®Google Scholar
• Zhang, Y., Y. Xiong, and W. G. Yarbrough. 1998. ARF promotes MDM2 degradation and stabilizes p53: ARF-INK4a locus deletion impairs both the Rb and p53 tumor suppression pathways. Cell 92: 725–734.
   PubMed Web of Science ®Google Scholar